Literature DB >> 17042927

The immunology of parasite infections in immunocompromised hosts.

T Evering1, L M Weiss.   

Abstract

Immune compromise can modify the severity and manifestation of some parasitic infections. More widespread use of newer immnosuppressive therapies, the growing population of individuals with immunocompromised states as well as the prolonged survival of these patients have altered the pattern of parasitic infection. This review article discusses the burden and immunology of parasitic infections in patients who are immunocompromised secondary to congenital immunodeficiency, malnutrition, malignancy, and immunosuppressive medications. This review does not address the literature on parasitic infections in the setting of HIV-1 infection.

Entities:  

Mesh:

Year:  2006        PMID: 17042927      PMCID: PMC3109637          DOI: 10.1111/j.1365-3024.2006.00886.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  227 in total

Review 1.  Pneumocystis pneumonia.

Authors:  Charles F Thomas; Andrew H Limper
Journal:  N Engl J Med       Date:  2004-06-10       Impact factor: 91.245

2.  Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice.

Authors:  J R Mead; M J Arrowood; R W Sidwell; M C Healey
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

3.  In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.

Authors:  T M Scharton-Kersten; T A Wynn; E Y Denkers; S Bala; E Grunvald; S Hieny; R T Gazzinelli; A Sher
Journal:  J Immunol       Date:  1996-11-01       Impact factor: 5.422

4.  Alveolar damage in AIDS-related Pneumocystis carinii pneumonia.

Authors:  T L Benfield; P Prentø; J Junge; J Vestbo; J D Lundgren
Journal:  Chest       Date:  1997-05       Impact factor: 9.410

5.  Localization of alpha/beta and gamma/delta T lymphocytes in Cryptosporidium parvum-infected tissues in naive and immune calves.

Authors:  M S Abrahamsen; C A Lancto; B Walcheck; W Layton; M A Jutila
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

6.  Role of interleukin-6 in the control of acute and chronic Giardia lamblia infections in mice.

Authors:  Ping Zhou; Erqiu Li; Nannan Zhu; Jason Robertson; Theodore Nash; Steven M Singer
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

7.  Experimental microsporidiosis in immunocompetent and immunodeficient mice and monkeys.

Authors:  E S Didier; P W Varner; P J Didier; A M Aldras; N J Millichamp; M Murphey-Corb; R Bohm; J A Shadduck
Journal:  Folia Parasitol (Praha)       Date:  1994       Impact factor: 2.122

8.  Intestinal pathology during acute toxoplasmosis is IL-4 dependent and unrelated to parasite burden.

Authors:  M B Nickdel; R E Lyons; F Roberts; F Brombacher; C A Hunter; J Alexander; C W Roberts
Journal:  Parasite Immunol       Date:  2004-02       Impact factor: 2.280

Review 9.  Syndrome of hyperinfection with Strongyloides stercoralis.

Authors:  Y Igra-Siegman; R Kapila; P Sen; Z C Kaminski; D B Louria
Journal:  Rev Infect Dis       Date:  1981 May-Jun

10.  Properties of the major antigens of rat and human Pneumocystis carinii.

Authors:  M J Linke; M T Cushion; P D Walzer
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

View more
  22 in total

1.  Cellular immune response and scanning electron microscopy in the evaluation of Moringa leaves aqueous extract effect on Cryptosporidium parvum in buffalo intestinal tissue explants.

Authors:  Dina Aboelsoued; Nagwa I Toaleb; Kadria N Abdel Megeed; Soad E Hassan; Sally Ibrahim
Journal:  J Parasit Dis       Date:  2019-03-18

2.  Toxoplasma gondii in cancer patients receiving chemotherapy: seroprevalence and interferon gamma level.

Authors:  Mona Ibrahim Ali; Wegdan Mohamed Abd El Wahab; Doaa Ahmed Hamdy; Ahmed Hassan
Journal:  J Parasit Dis       Date:  2019-03-30

3.  Cryptosporidium infection among people living with HIV/AIDS in Ethiopia: a systematic review and meta-analysis.

Authors:  Mehdi Mohebali; Yonas Yimam; Ambachew Woreta
Journal:  Pathog Glob Health       Date:  2020-04-03       Impact factor: 2.894

4.  Watch and Wait Approach for Inactive Echinococcal Cyst of the Liver: An Update.

Authors:  Raffaella Lissandrin; Francesca Tamarozzi; Mara Mariconti; Tommaso Manciulli; Enrico Brunetti; Ambra Vola
Journal:  Am J Trop Med Hyg       Date:  2018-05-31       Impact factor: 2.345

5.  Prevalence and Predisposing Factors of Intestinal Parasitic Infections Among HIV Positive Patients Visiting Nekemte Specialized Hospital, Western Ethiopia.

Authors:  Robsen Miressa; Mebrate Dufera
Journal:  HIV AIDS (Auckl)       Date:  2021-05-14

6.  Prevalence of Intestinal Parasitic Infection among HIV Positive Persons Who Are Naive and on Antiretroviral Treatment in Hiwot Fana Specialized University Hospital, Eastern Ethiopia.

Authors:  Zelalem Teklemariam; Degu Abate; Habtamu Mitiku; Yadeta Dessie
Journal:  ISRN AIDS       Date:  2013-06-11

Review 7.  Strongyloidiasis--an insight into its global prevalence and management.

Authors:  Santhosh Puthiyakunnon; Swapna Boddu; Yiji Li; Xiaohong Zhou; Chunmei Wang; Juan Li; Xiaoguang Chen
Journal:  PLoS Negl Trop Dis       Date:  2014-08-14

8.  Intestinal parasitic infections in relation to HIV/AIDS status, diarrhea and CD4 T-cell count.

Authors:  Shimelis Assefa; Berhanu Erko; Girmay Medhin; Zelalem Assefa; Techalew Shimelis
Journal:  BMC Infect Dis       Date:  2009-09-18       Impact factor: 3.090

9.  Seroepidemiology of Toxoplasma gondii infection in patients with liver disease in eastern China.

Authors:  A L Tian; G X Li; H M Elsheikha; D S Gardner; X Y Zhang; W Dong; X P Yang; Y Y Luo; H L Li; W Cong; X Q Zhu
Journal:  Epidemiol Infect       Date:  2017-07-05       Impact factor: 4.434

10.  Does Toxoplasma gondii infection affect the levels of IgE and cytokines (IL-5, IL-6, IL-10, IL-12, and TNF-alpha)?

Authors:  Joanna Matowicka-Karna; Violetta Dymicka-Piekarska; Halina Kemona
Journal:  Clin Dev Immunol       Date:  2009-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.